ZURI Canadian Trademark Information

On Wednesday, May 31, 2017, a canadian trademark registration was filed for ZURI by Zuri Canada Corporation *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1840159. The current status of this trademark filing is Registration published. The ZURI trademark is filed in the description of Manufacturing, processing, and distributing of pharmaceutical products, food supplements, vitamins, and ointments. , Pharmaceutical preparations, namely vitamins, food supplements, herbs, teas, beverages, herbal supplements for general health and well-being; medicinal marijuana for temporary relief of seizures; medicinal marijuana for the relief of nausea caused by chemotherapy; medicinal marijuana for the treatment of muscle spasms caused by multiple sclerosis; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the use in oncology; , Manufacturing, processing, growing, and distributing of pharmaceutical products, toiletries, food supplements, vitamins, ointments and wellness products , Pharmaceutical preparations, namely drugs, vitamins, ointments, toiletries, medical liquids, food supplements, herbs, teas, beverages, herbal supplements for general health and well-being; medicinal marijuana for temporary relief of seizures; medicinal marijuana for the relief of nausea caused by chemotherapy; medicinal marijuana for the treatment of muscle spasms caused by multiple sclerosis; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for use in oncology; .